P154 A pathway transformation to transition from a ‘routine’ to a ‘responsive’ severe asthma service in the post COVID era
BackgroundHistorical care delivery models in severe asthma have resulted in an extensive burden of long-term follow-up within services leading to significant waiting lists for ‘routine’ appointments. This was exacerbated by the COVID-19 pandemic creating an urgent need to address rising waiting list...
Gespeichert in:
Veröffentlicht in: | Thorax 2021-11, Vol.76 (Suppl 2), p.A151-A152 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | A152 |
---|---|
container_issue | Suppl 2 |
container_start_page | A151 |
container_title | Thorax |
container_volume | 76 |
creator | Wiffen, L Harvey, R Fox, L Mathias, A Harbour, K Chauhan, AJ Brown, T |
description | BackgroundHistorical care delivery models in severe asthma have resulted in an extensive burden of long-term follow-up within services leading to significant waiting lists for ‘routine’ appointments. This was exacerbated by the COVID-19 pandemic creating an urgent need to address rising waiting lists and implement novel care pathways maximising remote support for patients whilst ensuring prompt access to the team at a time of clinical need and the continued delivery of safe and effective patient-centred care.MethodsA comprehensive review of the clinic footprint identified 646 patients with difficult or severe asthma awaiting ‘routine’ follow-up (outside of a treatment pathway). A manual risk stratification tool was developed in collaboration with our patient representatives and MDT, with patients triaged into multi-disciplinary clinic streams through a collaborative clinical and administrative process (ensuring previous waiting times, patient risk and need for MDT interventions/treatments were considered). All reviews were undertaken remotely with face to face appointments only where clinical benefits outweighed the risk. A PDSA process was used to concurrently assess the processes for risk stratification, patient discussion and clinic transition.Results638 patients were reviewed May-September 2020 with 59% requiring continued follow-up within the asthma service and 30% safely transitioned from routine follow-up to remote supervision with review at the time of need. 8% were discharged with an SOS appointment and 3% were followed up in an alternative respiratory clinic. The process was well received by patients with the majority feeling confident with their follow-up arrangements. Phenotypic details have been recorded to ensure timely review and access to novel therapies where these become available.Abstract P154 Figure 1A pathway transformation to transition from a ‘routine’ to a ‘responsive’ severe asthma service in the post COVID eraConclusionsThe COVID-19 pandemic has necessitated a comprehensive re-evaluation of services and care pathways across the NHS. Transitioning from a ‘routine’ to ‘responsive’ patient-triggered service has facilitated flexible but personalised care empowering patients in the self-management of their asthma and significantly reducing the burden of ‘routine’ follow-up for patients and the MDT. This has reduced waiting times and increased capacity for new patient assessments whilst ensuring patients are offered timely reviews when |
doi_str_mv | 10.1136/thorax-2021-BTSabstracts.263 |
format | Article |
fullrecord | <record><control><sourceid>proquest_bmj_j</sourceid><recordid>TN_cdi_proquest_journals_2594960572</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2594960572</sourcerecordid><originalsourceid>FETCH-LOGICAL-b1313-bf99168b8cfa7e59f867c2ef41589faa45af95dd4fedc9a67052f6295f8318c03</originalsourceid><addsrcrecordid>eNpNkM1KAzEUhYMoWKvvENDt1PxMMsmy1r9CoYLV7XBnmtApTlOTtOquC30Hfb0-iVNH0NXlHD7OhQ-hM0p6lHJ5HmfOw2vCCKPJxeQeihA9lDH0mOR7qENTqRLOtNxHHUJSkkieyUN0FMKcEKIozTro_Y6KdLv56OMlxNkLvOFmYhGs8zXEyi1wdG1T_STrXY0Bbzef3q1itTDbzdcOaSsTlq4h1z9tMGvjDYYQZzU0ya-r0uCqWZwZvHQh4sH4cXiJjYdjdGDhKZiT39tFD9dXk8FtMhrfDAf9UVJQTnlSWK2pVIUqLWRGaKtkVjJjUyqUtgCpAKvFdJpaMy01yIwIZiXTwipOVUl4F522u0vvnlcmxHzuVn7RvMyZ0KmWRGSsoVRLFfX8D6Ak3znPW-f5znn-33neOOffXzSBQA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2594960572</pqid></control><display><type>article</type><title>P154 A pathway transformation to transition from a ‘routine’ to a ‘responsive’ severe asthma service in the post COVID era</title><source>Alma/SFX Local Collection</source><creator>Wiffen, L ; Harvey, R ; Fox, L ; Mathias, A ; Harbour, K ; Chauhan, AJ ; Brown, T</creator><creatorcontrib>Wiffen, L ; Harvey, R ; Fox, L ; Mathias, A ; Harbour, K ; Chauhan, AJ ; Brown, T</creatorcontrib><description>BackgroundHistorical care delivery models in severe asthma have resulted in an extensive burden of long-term follow-up within services leading to significant waiting lists for ‘routine’ appointments. This was exacerbated by the COVID-19 pandemic creating an urgent need to address rising waiting lists and implement novel care pathways maximising remote support for patients whilst ensuring prompt access to the team at a time of clinical need and the continued delivery of safe and effective patient-centred care.MethodsA comprehensive review of the clinic footprint identified 646 patients with difficult or severe asthma awaiting ‘routine’ follow-up (outside of a treatment pathway). A manual risk stratification tool was developed in collaboration with our patient representatives and MDT, with patients triaged into multi-disciplinary clinic streams through a collaborative clinical and administrative process (ensuring previous waiting times, patient risk and need for MDT interventions/treatments were considered). All reviews were undertaken remotely with face to face appointments only where clinical benefits outweighed the risk. A PDSA process was used to concurrently assess the processes for risk stratification, patient discussion and clinic transition.Results638 patients were reviewed May-September 2020 with 59% requiring continued follow-up within the asthma service and 30% safely transitioned from routine follow-up to remote supervision with review at the time of need. 8% were discharged with an SOS appointment and 3% were followed up in an alternative respiratory clinic. The process was well received by patients with the majority feeling confident with their follow-up arrangements. Phenotypic details have been recorded to ensure timely review and access to novel therapies where these become available.Abstract P154 Figure 1A pathway transformation to transition from a ‘routine’ to a ‘responsive’ severe asthma service in the post COVID eraConclusionsThe COVID-19 pandemic has necessitated a comprehensive re-evaluation of services and care pathways across the NHS. Transitioning from a ‘routine’ to ‘responsive’ patient-triggered service has facilitated flexible but personalised care empowering patients in the self-management of their asthma and significantly reducing the burden of ‘routine’ follow-up for patients and the MDT. This has reduced waiting times and increased capacity for new patient assessments whilst ensuring patients are offered timely reviews when their asthma control deteriorates, delivering equitable access across the system with the potential to improve patient outcomes.</description><identifier>ISSN: 0040-6376</identifier><identifier>EISSN: 1468-3296</identifier><identifier>DOI: 10.1136/thorax-2021-BTSabstracts.263</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and British Thoracic Society</publisher><subject>Asthma ; Collaboration ; Coronaviruses ; COVID-19 ; New treatment pathways in the post-COVID-19 era ; Pandemics ; Patients</subject><ispartof>Thorax, 2021-11, Vol.76 (Suppl 2), p.A151-A152</ispartof><rights>Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.</rights><rights>2021 Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Wiffen, L</creatorcontrib><creatorcontrib>Harvey, R</creatorcontrib><creatorcontrib>Fox, L</creatorcontrib><creatorcontrib>Mathias, A</creatorcontrib><creatorcontrib>Harbour, K</creatorcontrib><creatorcontrib>Chauhan, AJ</creatorcontrib><creatorcontrib>Brown, T</creatorcontrib><title>P154 A pathway transformation to transition from a ‘routine’ to a ‘responsive’ severe asthma service in the post COVID era</title><title>Thorax</title><addtitle>Thorax</addtitle><description>BackgroundHistorical care delivery models in severe asthma have resulted in an extensive burden of long-term follow-up within services leading to significant waiting lists for ‘routine’ appointments. This was exacerbated by the COVID-19 pandemic creating an urgent need to address rising waiting lists and implement novel care pathways maximising remote support for patients whilst ensuring prompt access to the team at a time of clinical need and the continued delivery of safe and effective patient-centred care.MethodsA comprehensive review of the clinic footprint identified 646 patients with difficult or severe asthma awaiting ‘routine’ follow-up (outside of a treatment pathway). A manual risk stratification tool was developed in collaboration with our patient representatives and MDT, with patients triaged into multi-disciplinary clinic streams through a collaborative clinical and administrative process (ensuring previous waiting times, patient risk and need for MDT interventions/treatments were considered). All reviews were undertaken remotely with face to face appointments only where clinical benefits outweighed the risk. A PDSA process was used to concurrently assess the processes for risk stratification, patient discussion and clinic transition.Results638 patients were reviewed May-September 2020 with 59% requiring continued follow-up within the asthma service and 30% safely transitioned from routine follow-up to remote supervision with review at the time of need. 8% were discharged with an SOS appointment and 3% were followed up in an alternative respiratory clinic. The process was well received by patients with the majority feeling confident with their follow-up arrangements. Phenotypic details have been recorded to ensure timely review and access to novel therapies where these become available.Abstract P154 Figure 1A pathway transformation to transition from a ‘routine’ to a ‘responsive’ severe asthma service in the post COVID eraConclusionsThe COVID-19 pandemic has necessitated a comprehensive re-evaluation of services and care pathways across the NHS. Transitioning from a ‘routine’ to ‘responsive’ patient-triggered service has facilitated flexible but personalised care empowering patients in the self-management of their asthma and significantly reducing the burden of ‘routine’ follow-up for patients and the MDT. This has reduced waiting times and increased capacity for new patient assessments whilst ensuring patients are offered timely reviews when their asthma control deteriorates, delivering equitable access across the system with the potential to improve patient outcomes.</description><subject>Asthma</subject><subject>Collaboration</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>New treatment pathways in the post-COVID-19 era</subject><subject>Pandemics</subject><subject>Patients</subject><issn>0040-6376</issn><issn>1468-3296</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpNkM1KAzEUhYMoWKvvENDt1PxMMsmy1r9CoYLV7XBnmtApTlOTtOquC30Hfb0-iVNH0NXlHD7OhQ-hM0p6lHJ5HmfOw2vCCKPJxeQeihA9lDH0mOR7qENTqRLOtNxHHUJSkkieyUN0FMKcEKIozTro_Y6KdLv56OMlxNkLvOFmYhGs8zXEyi1wdG1T_STrXY0Bbzef3q1itTDbzdcOaSsTlq4h1z9tMGvjDYYQZzU0ya-r0uCqWZwZvHQh4sH4cXiJjYdjdGDhKZiT39tFD9dXk8FtMhrfDAf9UVJQTnlSWK2pVIUqLWRGaKtkVjJjUyqUtgCpAKvFdJpaMy01yIwIZiXTwipOVUl4F522u0vvnlcmxHzuVn7RvMyZ0KmWRGSsoVRLFfX8D6Ak3znPW-f5znn-33neOOffXzSBQA</recordid><startdate>20211108</startdate><enddate>20211108</enddate><creator>Wiffen, L</creator><creator>Harvey, R</creator><creator>Fox, L</creator><creator>Mathias, A</creator><creator>Harbour, K</creator><creator>Chauhan, AJ</creator><creator>Brown, T</creator><general>BMJ Publishing Group Ltd and British Thoracic Society</general><general>BMJ Publishing Group LTD</general><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20211108</creationdate><title>P154 A pathway transformation to transition from a ‘routine’ to a ‘responsive’ severe asthma service in the post COVID era</title><author>Wiffen, L ; Harvey, R ; Fox, L ; Mathias, A ; Harbour, K ; Chauhan, AJ ; Brown, T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b1313-bf99168b8cfa7e59f867c2ef41589faa45af95dd4fedc9a67052f6295f8318c03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Asthma</topic><topic>Collaboration</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>New treatment pathways in the post-COVID-19 era</topic><topic>Pandemics</topic><topic>Patients</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wiffen, L</creatorcontrib><creatorcontrib>Harvey, R</creatorcontrib><creatorcontrib>Fox, L</creatorcontrib><creatorcontrib>Mathias, A</creatorcontrib><creatorcontrib>Harbour, K</creatorcontrib><creatorcontrib>Chauhan, AJ</creatorcontrib><creatorcontrib>Brown, T</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Thorax</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wiffen, L</au><au>Harvey, R</au><au>Fox, L</au><au>Mathias, A</au><au>Harbour, K</au><au>Chauhan, AJ</au><au>Brown, T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>P154 A pathway transformation to transition from a ‘routine’ to a ‘responsive’ severe asthma service in the post COVID era</atitle><jtitle>Thorax</jtitle><stitle>Thorax</stitle><date>2021-11-08</date><risdate>2021</risdate><volume>76</volume><issue>Suppl 2</issue><spage>A151</spage><epage>A152</epage><pages>A151-A152</pages><issn>0040-6376</issn><eissn>1468-3296</eissn><abstract>BackgroundHistorical care delivery models in severe asthma have resulted in an extensive burden of long-term follow-up within services leading to significant waiting lists for ‘routine’ appointments. This was exacerbated by the COVID-19 pandemic creating an urgent need to address rising waiting lists and implement novel care pathways maximising remote support for patients whilst ensuring prompt access to the team at a time of clinical need and the continued delivery of safe and effective patient-centred care.MethodsA comprehensive review of the clinic footprint identified 646 patients with difficult or severe asthma awaiting ‘routine’ follow-up (outside of a treatment pathway). A manual risk stratification tool was developed in collaboration with our patient representatives and MDT, with patients triaged into multi-disciplinary clinic streams through a collaborative clinical and administrative process (ensuring previous waiting times, patient risk and need for MDT interventions/treatments were considered). All reviews were undertaken remotely with face to face appointments only where clinical benefits outweighed the risk. A PDSA process was used to concurrently assess the processes for risk stratification, patient discussion and clinic transition.Results638 patients were reviewed May-September 2020 with 59% requiring continued follow-up within the asthma service and 30% safely transitioned from routine follow-up to remote supervision with review at the time of need. 8% were discharged with an SOS appointment and 3% were followed up in an alternative respiratory clinic. The process was well received by patients with the majority feeling confident with their follow-up arrangements. Phenotypic details have been recorded to ensure timely review and access to novel therapies where these become available.Abstract P154 Figure 1A pathway transformation to transition from a ‘routine’ to a ‘responsive’ severe asthma service in the post COVID eraConclusionsThe COVID-19 pandemic has necessitated a comprehensive re-evaluation of services and care pathways across the NHS. Transitioning from a ‘routine’ to ‘responsive’ patient-triggered service has facilitated flexible but personalised care empowering patients in the self-management of their asthma and significantly reducing the burden of ‘routine’ follow-up for patients and the MDT. This has reduced waiting times and increased capacity for new patient assessments whilst ensuring patients are offered timely reviews when their asthma control deteriorates, delivering equitable access across the system with the potential to improve patient outcomes.</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and British Thoracic Society</pub><doi>10.1136/thorax-2021-BTSabstracts.263</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0040-6376 |
ispartof | Thorax, 2021-11, Vol.76 (Suppl 2), p.A151-A152 |
issn | 0040-6376 1468-3296 |
language | eng |
recordid | cdi_proquest_journals_2594960572 |
source | Alma/SFX Local Collection |
subjects | Asthma Collaboration Coronaviruses COVID-19 New treatment pathways in the post-COVID-19 era Pandemics Patients |
title | P154 A pathway transformation to transition from a ‘routine’ to a ‘responsive’ severe asthma service in the post COVID era |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T04%3A43%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_bmj_j&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=P154%E2%80%85A%20pathway%20transformation%20to%20transition%20from%20a%20%E2%80%98routine%E2%80%99%20to%20a%20%E2%80%98responsive%E2%80%99%20severe%20asthma%20service%20in%20the%20post%20COVID%20era&rft.jtitle=Thorax&rft.au=Wiffen,%20L&rft.date=2021-11-08&rft.volume=76&rft.issue=Suppl%202&rft.spage=A151&rft.epage=A152&rft.pages=A151-A152&rft.issn=0040-6376&rft.eissn=1468-3296&rft_id=info:doi/10.1136/thorax-2021-BTSabstracts.263&rft_dat=%3Cproquest_bmj_j%3E2594960572%3C/proquest_bmj_j%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2594960572&rft_id=info:pmid/&rfr_iscdi=true |